File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: The anti-scarring role of Lycium barbarum polysaccharride on cornea epithelial-stromal injury - an eye-on-a-chip study
Title | The anti-scarring role of Lycium barbarum polysaccharride on cornea epithelial-stromal injury - an eye-on-a-chip study |
---|---|
Authors | |
Issue Date | 2020 |
Publisher | European Society of Cataract and Refractive Surgeons. |
Citation | The 38th European Society of Cataract and Refractive Surgeons (ESCRS) Annual Congress, Virtual Conference, 2-4 October 2020 How to Cite? |
Abstract | Purpose: The study is to assess whether Lycium barbarum polysaccharide (LBP) solution can be a novel therapy in modulating keratocytes differentiation after corneal epithelial- stromal injury in an eye-on-a-chip model.
Setting: Stromal scarring of the cornea is the fourth common cause of global blindness, which contributes to 5.1% of the cases. The outcome of stromal scarring primarily depends on keratocytes differentiation. Under the action of transforming growth factor-beta 1, quiescent keratocytes will phenotypically differentiate into opaque myofibroblasts, leading to corneal haze.
Methods: A 3D model made of PDMS elastomers is created to mimic the anatomy and physiology of the corneal stroma. The chip consists of a cell culture chamber and is connected to two channels where medium or LBP is supplied. Human keratocytes are suspended in collagen to form a three-dimensional hydrogel construct. Cells are pre-treated with 2 mg/mL LBP or 10-4M Dexamethasone for 24 hours, followed by 10 ng/mL TGF-1 for another 24 hours.
Results: Cells pre-treated with LBP showed a decreased expression of alpha-smooth muscle actin, which is a prominent marker of myofibroblasts. Pro-fibrotic proteins such as vimentin, collagen II and collagen III are as well reduced. Cell-laden hydrogel pre-treated with LBP revealed no significant contraction compared to that in control group (p=0.29) while group pre-treated with TGF- showed increased contraction by 17.3% (p<0.001). The stiffness of the hydrogel treated with TGF-1 alone had an increase by 3.55-fold (p=0.02) yet that in the LBP group showed no significant difference compared to that in control group (p=0.9964)
Conclusions: LBP can be a potential topical therapy to prevent corneal scarring prior to surgery. Optimized LBP concentration can potentially lead to fewer adverse effects compared to standard pharmacological treatments while minimizing keratocyte differentiation. |
Description | Poster Presentation - Cornea: Medical |
Persistent Identifier | http://hdl.handle.net/10722/296352 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, HL | - |
dc.contributor.author | Shih, KC | - |
dc.contributor.author | Chan, YK | - |
dc.contributor.author | Lo, ACY | - |
dc.contributor.author | Poon, S | - |
dc.date.accessioned | 2021-02-22T04:54:05Z | - |
dc.date.available | 2021-02-22T04:54:05Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | The 38th European Society of Cataract and Refractive Surgeons (ESCRS) Annual Congress, Virtual Conference, 2-4 October 2020 | - |
dc.identifier.uri | http://hdl.handle.net/10722/296352 | - |
dc.description | Poster Presentation - Cornea: Medical | - |
dc.description.abstract | Purpose: The study is to assess whether Lycium barbarum polysaccharide (LBP) solution can be a novel therapy in modulating keratocytes differentiation after corneal epithelial- stromal injury in an eye-on-a-chip model. Setting: Stromal scarring of the cornea is the fourth common cause of global blindness, which contributes to 5.1% of the cases. The outcome of stromal scarring primarily depends on keratocytes differentiation. Under the action of transforming growth factor-beta 1, quiescent keratocytes will phenotypically differentiate into opaque myofibroblasts, leading to corneal haze. Methods: A 3D model made of PDMS elastomers is created to mimic the anatomy and physiology of the corneal stroma. The chip consists of a cell culture chamber and is connected to two channels where medium or LBP is supplied. Human keratocytes are suspended in collagen to form a three-dimensional hydrogel construct. Cells are pre-treated with 2 mg/mL LBP or 10-4M Dexamethasone for 24 hours, followed by 10 ng/mL TGF-1 for another 24 hours. Results: Cells pre-treated with LBP showed a decreased expression of alpha-smooth muscle actin, which is a prominent marker of myofibroblasts. Pro-fibrotic proteins such as vimentin, collagen II and collagen III are as well reduced. Cell-laden hydrogel pre-treated with LBP revealed no significant contraction compared to that in control group (p=0.29) while group pre-treated with TGF- showed increased contraction by 17.3% (p<0.001). The stiffness of the hydrogel treated with TGF-1 alone had an increase by 3.55-fold (p=0.02) yet that in the LBP group showed no significant difference compared to that in control group (p=0.9964) Conclusions: LBP can be a potential topical therapy to prevent corneal scarring prior to surgery. Optimized LBP concentration can potentially lead to fewer adverse effects compared to standard pharmacological treatments while minimizing keratocyte differentiation. | - |
dc.language | eng | - |
dc.publisher | European Society of Cataract and Refractive Surgeons. | - |
dc.relation.ispartof | 38th Congress of the European Society of Cataract and Refractive Surgeons | - |
dc.title | The anti-scarring role of Lycium barbarum polysaccharride on cornea epithelial-stromal injury - an eye-on-a-chip study | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Shih, KC: kcshih@hku.hk | - |
dc.identifier.email | Chan, YK: josephyk@connect.hku.hk | - |
dc.identifier.email | Lo, ACY: amylo@hku.hk | - |
dc.identifier.authority | Shih, KC=rp01374 | - |
dc.identifier.authority | Chan, YK=rp02536 | - |
dc.identifier.authority | Lo, ACY=rp00425 | - |
dc.identifier.hkuros | 321362 | - |